Agfa-Gevaert Group and Dedalus sign share purchase agreement for sale of part of Agfa HealthCare’s IT business - Regulated information
Mortsel, Belgium – January 29, 2020 – 7.45 a.m. CET
As announced on December 2, 2019, the Board of Directors of the Agfa-Gevaert Group decided to enter into exclusive negotiations with Dedalus Holding S.p.A. to sell a part of Agfa HealthCare’s IT business (the “Business”). Today, both parties announce that they have signed the share purchase agreement, under which Dedalus S.p.A. would acquire 100% of the Business at an enterprise value of 975 million Euro, subject to regular working capital and net debt adjustments.
The transaction is subject to customary employees’ consultations, regulatory approvals and closing conditions. Both parties aim to close the transaction in the course of Q2 2020.
The Business consists of the Healthcare Information Solutions and Integrated Care activities, as well as the Imaging IT activities to the extent that these activities are tightly integrated into the Healthcare Information Solutions activities. This is the case mainly in the DACH region, France and Brazil.
End of message
About Agfa
The Agfa-Gevaert Group develops, manufactures and distributes an extensive range of analogue and digital imaging systems and IT solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications.
Agfa’s headquarters and parent company are located in Mortsel, Belgium.
The Agfa-Gevaert Group achieved a turnover of 2,247 million euro in 2018.
Contact:
Viviane Dictus
Director Corporate Communications
tel. 4
e-mail:
About Dedalus
Founded in 1990 in Florence, Dedalus, with over 2.000 employees, of which 1.200 in Italy, 550 in France and teams in 25 countries, is an international industrial group in the healthcare software industry specialized in the segment of diagnostic and clinical management solutions (HCIS), GPs and Primary care management, Interoperability and Population health management.
In 2016, the European Private Equity Fund Ardian acquired the 60% of the Dedalus Group boosting its international expansion and strengthening the R&D activities, which is now composed by more than 600 people.
Today, Dedalus exploits the full functional coverage of all ICT needs of any healthcare system, not limited to hospital systems, both public and private. In the last three years, Dedalus has totally renewed its offering, by addressing the state of art of paradigm in terms of technology and functionalities to anticipate the evolution of the clinical practice at the base of the change management of different healthcare system that in many countries are rethinking their organizations.
With more than 130 million euros of revenues in Italy, more than 60 million euros in France and globally more than 210 million euros, Dedalus is one of the leading global players in the sector and holds a leading position in Europe.
Contact:
Elisabetta Natali,
Communication Director
Attachment
